Get the Stockscreener App
31.37
6.50%
1.9955
Indivior Plc stock is traded at $31.37, with a volume of 3.12M.
It is up +6.50% in the last 24 hours and up +35.00% over the past month.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$29.37
Open:
$30
24h Volume:
3.12M
Relative Volume:
1.43
Market Cap:
$3.67B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
3,136.55
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
+26.23%
1M Performance:
+35.00%
6M Performance:
+161.10%
1Y Performance:
+234.55%
1-Day Range:
$29.55
$31.63
1-Week Range:
$24.28
$31.63
52-Week Range:
$7.62
$31.63
Indivior Plc Stock (INDV) Company Profile
Name
Indivior Plc
Sector
Phone
804-379-1090
Address
234 BATH ROAD, SLOUGH, BERKSHIRE
Compare INDV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
31.29 | 3.67B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
144.53 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.43 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.3855 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.50 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
436.52 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Initiated | H.C. Wainwright | Buy |
| Jul-22-25 | Resumed | Jefferies | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
View All
Indivior Plc Stock (INDV) Latest News
Leading vs lagging indicators on Indivior PLC performance2025 Institutional Moves & Long-Term Safe Investment Ideas - newser.com
Is Indivior PLC stock bottoming outJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Monthly buprenorphine treatment shows lower relapse rates in OUD patients - Investing.com
Intraday pattern recognizer results for Indivior PLC2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - newser.com
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine - PR Newswire
Applying chart zones and confluence areas to Indivior PLCJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Why analysts upgrade Indivior PLC stock2025 Stock Rankings & Consistent Profit Alerts - newser.com
Can Indivior PLC stock reach $100 price target2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
Will Indivior PLC stock deliver long term returns2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com
Real time scanner hits for Indivior PLC explainedQuarterly Portfolio Review & High Return Trade Guides - newser.com
Will Indivior PLC stock benefit from infrastructure spending2025 Stock Rankings & Scalable Portfolio Growth Ideas - newser.com
Can Indivior PLC stock beat market expectations this quarterWeekly Loss Report & Weekly High Return Stock Forecasts - newser.com
Indivior PLC 2025 Q3ResultsEarnings Call Presentation (NASDAQ:INDV) 2025-11-01 - Seeking Alpha
Is Indivior PLC (2IVB) stock attractive post correction2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
Indivior outlines $150M OpEx savings and raises 2025 revenue guidance to $1.22B as SUBLOCADE growth accelerates - MSN
How Indivior PLC stock trades during market volatility2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
Indivior PLC’s Optimistic Earnings Call Highlights Growth - TipRanks
Indivior PLC (INDV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Here's Why Indivior Stock Soared 15% Today - MSN
Indivior (INDV) Jumps to New High on Earnings Blowout, Optimistic Outlook - MSN
Indivior price target raised to $40 from $30 at Northland - TipRanks
Indivior price target raised to $41 from $34 at Craig-Hallum - TipRanks
Indivior stock hits all-time high at 30.55 USD By Investing.com - Investing.com Australia
Using RSI to spot recovery in Indivior PLC2025 Sector Review & Stock Portfolio Risk Control - newser.com
Published on: 2025-10-31 05:08:49 - newser.com
Is Indivior PLC stock attractive for income investorsGold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Using Python tools to backtest Indivior PLC strategiesMarket Growth Report & Safe Swing Trade Setups - newser.com
Indivior PLC (INDV) Beats Q3 Earnings and Revenue Estimates - sharewise.com
How Indivior PLC stock performs in rising dollar environment2025 Big Picture & Capital Efficiency Focused Ideas - newser.com
Earnings call transcript: Indivior Q3 2025 beats expectations, stock surges By Investing.com - Investing.com Philippines
Indivior (INDV) One-Off $165M Loss Challenges Bullish Profit Growth Narratives - Sahm
Indivior PLC Reports Q3 2025 Results and Optimizes Strategy - TipRanks
Indivior PLC (INDV) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Healthcare Sector Rides A Wave Of Improved Earnings And Deals - Finimize
Indivior PLC (INDV) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Indivior PLC (INDV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Indivior Plc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.02%
1.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):